Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation

Por Aupetit, Jean-François, Loufoua-Moundanga, Joseph, Faucon, Georges, Timour, Quadiri
Publicado em 1997

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

Por Puymirat, Etienne, Riant, Elisabeth, Aissoui, Nadia, Soria, Angèle, Ducrocq, Gregory, Coste, Pierre, Cottin, Yves, Aupetit, Jean François, Bonnefoy, Eric, Blanchard, Didier, Cattan, Simon, Steg, Gabriel, Schiele, François, Ferrières, Jean, Juillière, Yves, Simon, Tabassome, Danchin, Nicolas
Publicado no BMJ (2016)

A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy

Por Villard, Eric, Perret, Claire, Gary, Françoise, Proust, Carole, Dilanian, Gilles, Hengstenberg, Christian, Ruppert, Volker, Arbustini, Eloisa, Wichter, Thomas, Germain, Marine, Dubourg, Olivier, Tavazzi, Luigi, Aumont, Marie-Claude, DeGroote, Pascal, Fauchier, Laurent, Trochu, Jean-Noël, Gibelin, Pierre, Aupetit, Jean-François, Stark, Klaus, Erdmann, Jeanette, Hetzer, Roland, Roberts, Angharad M., Barton, Paul J.R., Regitz-Zagrosek, Vera, Aslam, Uzma, Duboscq-Bidot, Laëtitia, Meyborg, Matthias, Maisch, Bernhard, Madeira, Hugo, Waldenström, Anders, Galve, Enrique, Cleland, John G., Dorent, Richard, Roizes, Gerard, Zeller, Tanja, Blankenberg, Stefan, Goodall, Alison H., Cook, Stuart, Tregouet, David A., Tiret, Laurence, Isnard, Richard, Komajda, Michel, Charron, Philippe, Cambien, François
Publicado em 2011